EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Role of Melatonin in Management of COVID-19: A Systematic Review

Ghada Essam El-din Amin, Salwa Mostafa Mohammad Abdel Rahman, Rehab Mohamed Ali Mohamed, Mohamed Farouk Allam

Microbes, Infection and Chemotherapy · 2024-06-08 · 4 · e1982

DOI: 10.54034/mic.e1982 ↗

At a glance

Systematische Übersicht in Microbes, Infection and Chemotherapy, published online on 2024-06-08. Written by Ghada Essam El-din Amin and 3 co-authors. 32 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background: the COVID-19 pandemic has significantly impacted global healthcare and economic systems. The clinical manifestation of the disease varies from flu-like symptoms to severe pneumonia and, in some cases, death. Melatonin and its metabolites play a crucial role in immunomodulation and possess anti-oxidative properties, capable of directly and indirectly scavenging reactive oxygen species. Objective: the aim of the present systematic review was to assess the effectiveness of melatonin in the management of COVID-19 patients and its role in expediting the return of patients to their baseline health. Methodology: the literature review was conducted up to August 2022, resulting in the identification of 533 articles after sorting them by authors and year of publication. Following the removal of 223 duplicate articles, 310 abstracts were screened, leading to the exclusion of 281. Subsequently, 29 full-text studies were evaluated for eligibility, with 22 being excluded. Finally, seven studies met the inclusion criteria and were included for further qualitative and quantitative analyses. Results: the findings revealed a noteworthy reduction in hospital stay among patients who received melatonin compared to those who received a placebo (standardized mean difference: -0.50, Standard error: 0.15, 95% CI: -0.80, -0.20, P value: 0.001). Melatonin was associated with a significant decrease in mortality in COVID-19 patients when compared to the placebo (Pooled RR: 0.21, 95% CI: 0.08, 0.56, P value: 0.002). However, there were no significant differences between melatonin and placebo regarding the need for hospitalization, ICU admission, artificial ventilation, and the requirement for oxygen therapy. Conclusion: melatonin may decrease the mortality rate among patients with COVID-19. Melatonin may reduce the duration of hospital stay in patients with COVID-19. Melatonin had no effect on the following outcomes in COVID-19 patients: the need for hospitalization, ICU admission, artificial ventilation and the need for oxygen therapy.

Cite

APA

Amin, G. E. E., Rahman, S. M. M. A., Mohamed, R. M. A., & Allam, M. F. (2024). Role of Melatonin in Management of COVID-19: A Systematic Review. Microbes, Infection and Chemotherapy, 4, e1982. https://doi.org/10.54034/mic.e1982

Vancouver

Amin GEE, Rahman SMMA, Mohamed RMA, Allam MF. Role of Melatonin in Management of COVID-19: A Systematic Review. Microbes, Infection and Chemotherapy. 2024;4:e1982. doi:10.54034/mic.e1982

BibTeX
@article{Amin2024,
  author = {Amin, Ghada Essam El-din and Rahman, Salwa Mostafa Mohammad Abdel and Mohamed, Rehab Mohamed Ali and Allam, Mohamed Farouk},
  title = {Role of Melatonin in Management of COVID-19: A Systematic Review},
  journal = {Microbes, Infection and Chemotherapy},
  year = {2024},
  volume = {4},
  pages = {e1982},
  doi = {10.54034/mic.e1982}
}
Start for free →